Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: J Neurointerv Surg. 2012 Sep 12;5(6):528–533. doi: 10.1136/neurintsurg-2012-010504

Table 1.

Operator and Site Factors versus the Occurrence of a Hemorrhagic or Ischemic Event (n=34)

Factor # Sites or Operators # Patients Hemorrhagic or Ischemic Event
n(%) p-value* Difference (95% CI)

SAMMPRIS Site Enrollment
 High (≥ 12) 12 111 17 (15.3%) 0.85 −1.4% (−11.7% – 8.7%)
 Low (< 12) 36 102 17 (16.7%)

High-Enrolling Registry Site
 No 38 132 21 (15.9%) 0.99 −0.1% (−11.3% – 9.8%)
 Yes 10 81 13 (16.0%)

Primary Specialty of Interventionist
 Radiology 39 115 17 (14.8%) 0.28 1: 0.9% (−13.4% – 13.3%)
 Neurosurgery 18 72 10 (13.9%) 2: −12.1% (−38.7% – 7.3%)
 Neurology 6 26 7 (26.9%) 3: −13.0% (−39.5% – 7.9%)

Credentialing: # Study devices
 < 10 30 71 7 (9.9%) 0.11 −9.1% (−18.5% – 2.1%)
 ≥ 10 33 142 27 (19.0%)

Credentialing: # Aneurysm Stents
 < 6 29 116 21 (18.1%) 0.45 4.7% (−5.8% – 14.7%)
 ≥ 6 34 97 13 (13.4%)

# Years in Practice
 < 8 28 104 18 (17.3%) 0.71 2.6% (−7.5% – 12.9%)
 ≥ 8 35 109 16 (14.7%)

# SAMMPRIS PTAS Cases
 < 3 31 43 7 (16.3%) 0.99 0.4% (−10.6% – 15.9%)
 ≥ 3 32 170 27 (15.9%)
*

P-value for Fisher’s exact test comparing percentages among groups.

Difference between percentages, calculated as first group – second group, except for Primary Specialty (1: Radiology – Neurosurgery, 2: Radiology – Neurology, 3: Neurosurgery – Neurology).

Total in both groups exceeds 63 interventionists because individual interventionists had patients in both groups.

PTAS = Percutaneous Transluminal Angioplasty and Stenting, CI = Confidence Interval.